{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:53:32Z","timestamp":1791420812400,"version":"4.3.3"},"reference-count":43,"publisher":"European Respiratory Society (ERS)","issue":"3","license":[{"start":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T00:00:00Z","timestamp":1670976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.ersjournals.com\/user-licence"}],"funder":[{"name":"Fondo de Investigaci\u00f3n Sanitaria-Fondos FEDER","award":["CP18\/00028"],"award-info":[{"award-number":["CP18\/00028"]}]},{"name":"Fondo de Investigaci\u00f3n Sanitaria-Fondos FEDER","award":["PI13\/01512"],"award-info":[{"award-number":["PI13\/01512"]}]},{"name":"Fondo de Investigaci\u00f3n Sanitaria-Fondos FEDER","award":["PI16\/00201"],"award-info":[{"award-number":["PI16\/00201"]}]},{"name":"Fondo de Investigaci\u00f3n Sanitaria-Fondos FEDER","award":["PI19\/01363"],"award-info":[{"award-number":["PI19\/01363"]}]},{"name":"Fondo de Investigaci\u00f3n Sanitaria-Fondos FEDER","award":["PI19\/01612"],"award-info":[{"award-number":["PI19\/01612"]}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2022,10,20]]},"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Atherosclerosis is a common comorbidity of obstructive sleep apnoea (OSA) patients, caused by the interaction of dyslipidaemia and systemic inflammation. The OSA pro-inflammatory response is mediated by NLRP3 inflammasome activation, which requires a priming signal mediated by intermittent hypoxia (IH) and an activation signal provided by soluble stimulus present in plasma. Our objectives were to study oxidised low-density lipoprotein (oxLDL) expression in OSA patients with or without early subclinical atherosclerosis (eSA) as well as its contribution to NLRP3 activation and tissue factor (TF) release.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We analysed oxLDL, key components of the NLRP3 inflammasome cascade and TF in plasma and monocytes from OSA patients and non-apnoeic subjects, with or without eSA as determined by increased carotid intima\u2013media thickness without the appearance of atherosclerotic plaques. The oxLDL contribution to NLRP3 inflammasome activation was assessed using\n                      <jats:italic>in vitro<\/jats:italic>\n                      models.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      High levels of oxLDL were identified in plasma from OSA patients, particularly in those with eSA, as well as an overexpression of NLRP3 cascade components and TF. Furthermore,\n                      <jats:italic>in vitro<\/jats:italic>\n                      models showed that both oxLDL and plasma from OSA patients with eSA act synergistically with IH as a priming and activation signal of NLRP3 that enhances the inflammatory response, pyroptosis and TF release.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>OSA patients with eSA exhibit NLRP3 activation by IH and the presence of oxLDL capable of releasing TF, constituting a pathway for the interaction between dyslipidaemia and systemic inflammation in the development of atherosclerotic lesions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1183\/13993003.01401-2022","type":"journal-article","created":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T11:35:14Z","timestamp":1671017714000},"page":"2201401","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":36,"title":["Inflammasome activation mediated by oxidised low-density lipoprotein in patients with sleep apnoea and early subclinical atherosclerosis"],"prefix":"10.1183","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4549-0678","authenticated-orcid":false,"given":"Elena","family":"D\u00edaz-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sanz-Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Garc\u00eda-Tovar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Alfaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Cubero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana V.","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Marin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Cubillos-Zapata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7227-2238","authenticated-orcid":false,"given":"Francisco","family":"Garc\u00eda-R\u00edo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2022,12,14]]},"reference":[{"key":"2024102103085685000_61.3.2201401.1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000988"},{"key":"2024102103085685000_61.3.2201401.2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200503-340OC"},{"key":"2024102103085685000_61.3.2201401.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61622-0"},{"key":"2024102103085685000_61.3.2201401.4","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2001"},{"key":"2024102103085685000_61.3.2201401.5","doi-asserted-by":"crossref","first-page":"707529","DOI":"10.3389\/fcvm.2021.707529","article-title":"Role of lipid accumulation and inflammation in atherosclerosis: focus on molecular and cellular mechanisms","volume":"8","author":"Malekmohammad","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"2024102103085685000_61.3.2201401.6","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2639"},{"key":"2024102103085685000_61.3.2201401.7","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2014.38"},{"key":"2024102103085685000_61.3.2201401.8","doi-asserted-by":"publisher","DOI":"10.3390\/molecules19021651"},{"key":"2024102103085685000_61.3.2201401.9","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1164\/rccm.202106-1445OC","article-title":"Inflammasome activation: a keystone of proinflammatory response in obstructive sleep apnea","volume":"205","author":"Diaz-Garcia","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102103085685000_61.3.2201401.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.04.007"},{"key":"2024102103085685000_61.3.2201401.11","doi-asserted-by":"publisher","DOI":"10.1038\/nature15514"},{"key":"2024102103085685000_61.3.2201401.12","doi-asserted-by":"publisher","DOI":"10.1038\/nri3452"},{"key":"2024102103085685000_61.3.2201401.13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.atherosclerosis.2020.06.003","article-title":"Tissue factor in atherosclerosis and atherothrombosis","volume":"307","author":"Grover","year":"2020","journal-title":"Atherosclerosis"},{"key":"2024102103085685000_61.3.2201401.14","doi-asserted-by":"publisher","DOI":"10.1586\/erc.11.40"},{"key":"2024102103085685000_61.3.2201401.15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/cmi.2013.48","article-title":"CD36: linking lipids to the NLRP3 inflammasome, atherogenesis and atherothrombosis","volume":"11","author":"Oury","year":"2014","journal-title":"Cell Mol Immunol"},{"key":"2024102103085685000_61.3.2201401.16","doi-asserted-by":"crossref","first-page":"596","DOI":"10.5551\/jat.7179","article-title":"Dose-dependent modulation of tissue factor protein and procoagulant activity in human monocyte-derived macrophages by oxidized low density lipoprotein","volume":"18","author":"Meisel","year":"2011","journal-title":"J Atheroscler Thromb"},{"key":"2024102103085685000_61.3.2201401.17","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.14.5.790"},{"key":"2024102103085685000_61.3.2201401.18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI58969"},{"key":"2024102103085685000_61.3.2201401.19","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.atherosclerosis.2016.12.019","article-title":"Platelet tissue factor activity and membrane cholesterol are increased in hypercholesterolemia and normalized by rosuvastatin, but not by atorvastatin","volume":"257","author":"Panes","year":"2017","journal-title":"Atherosclerosis"},{"key":"2024102103085685000_61.3.2201401.20","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1471-2466-14-114","article-title":"Epigenetics modifications and subclinical atherosclerosis in obstructive sleep apnea: the EPIOSA study","volume":"14","author":"Marin","year":"2014","journal-title":"BMC Pulm Med"},{"key":"2024102103085685000_61.3.2201401.21","doi-asserted-by":"publisher","DOI":"10.1016\/S0300-8932(10)70014-2"},{"key":"2024102103085685000_61.3.2201401.22","doi-asserted-by":"crossref","first-page":"zsz285","DOI":"10.1093\/sleep\/zsz285","article-title":"Differential effect of intermittent hypoxia and sleep fragmentation on PD-1\/PD-L1 upregulation","volume":"43","author":"Cubillos-Zapata","year":"2020","journal-title":"Sleep"},{"key":"2024102103085685000_61.3.2201401.23","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.3390\/jcm9082378","article-title":"SMAD4 overexpression in patients with sleep apnoea may be associated with cardiometabolic comorbidities","volume":"9","author":"Diaz-Garcia","year":"2020","journal-title":"J Clin Med"},{"key":"2024102103085685000_61.3.2201401.24","doi-asserted-by":"crossref","first-page":"zsy236","DOI":"10.1093\/sleep\/zsy236","article-title":"Obstructive sleep apnea and dyslipidemia: from animal models to clinical evidence","volume":"42","author":"Barros","year":"2019","journal-title":"Sleep"},{"key":"2024102103085685000_61.3.2201401.25","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s11325-020-02089-y","article-title":"Circulating levels of oxidized low-density lipoprotein in patients with obstructive sleep apnea: a systematic review and meta-analysis","volume":"24","author":"Fadaei","year":"2020","journal-title":"Sleep Breath"},{"key":"2024102103085685000_61.3.2201401.26","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.atherosclerosis.2015.05.008","article-title":"An assessment of oxidized LDL in the lipid profiles of patients with obstructive sleep apnea and its association with both hypertension and dyslipidemia, and the impact of treatment with CPAP","volume":"241","author":"Feres","year":"2015","journal-title":"Atherosclerosis"},{"key":"2024102103085685000_61.3.2201401.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2005.04.024"},{"key":"2024102103085685000_61.3.2201401.28","doi-asserted-by":"publisher","DOI":"10.1007\/s12265-013-9469-9"},{"key":"2024102103085685000_61.3.2201401.29","doi-asserted-by":"crossref","first-page":"11811","DOI":"10.1016\/S0021-9258(19)50272-1","article-title":"CD36 is a receptor for oxidized low density lipoprotein","volume":"268","author":"Endemann","year":"1993","journal-title":"J Biol Chem"},{"key":"2024102103085685000_61.3.2201401.30","doi-asserted-by":"publisher","DOI":"10.1172\/JCI35535"},{"key":"2024102103085685000_61.3.2201401.31","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-09-512749"},{"key":"2024102103085685000_61.3.2201401.32","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2008.100537"},{"key":"2024102103085685000_61.3.2201401.33","doi-asserted-by":"crossref","first-page":"677","DOI":"10.5664\/jcsm.3800","article-title":"Oxidative stress in children with obstructive sleep apnea syndrome","volume":"10","author":"Tauman","year":"2014","journal-title":"J Clin Sleep Med"},{"key":"2024102103085685000_61.3.2201401.34","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00009709"},{"key":"2024102103085685000_61.3.2201401.35","doi-asserted-by":"crossref","first-page":"43648","DOI":"10.1038\/srep43648","article-title":"Aorta macrophage inflammatory and epigenetic changes in a murine model of obstructive sleep apnea: potential role of CD36","volume":"7","author":"Cortese","year":"2017","journal-title":"Sci Rep"},{"key":"2024102103085685000_61.3.2201401.36","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3389\/fmed.2020.00450","article-title":"Intrahepatic expression of fatty acid translocase CD36 is increased in obstructive sleep apnea","volume":"7","author":"Rey","year":"2020","journal-title":"Front Med"},{"key":"2024102103085685000_61.3.2201401.37","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1042\/CS20130043","article-title":"NLRP3 inflammasome activation in coronary artery disease: results from prospective and randomized study of treatment with atorvastatin or rosuvastatin","volume":"126","author":"Satoh","year":"2014","journal-title":"Clin Sci"},{"key":"2024102103085685000_61.3.2201401.38","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002128"},{"key":"2024102103085685000_61.3.2201401.39","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)11189-2"},{"key":"2024102103085685000_61.3.2201401.40","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.91.3.619"},{"key":"2024102103085685000_61.3.2201401.41","doi-asserted-by":"crossref","first-page":"7528","DOI":"10.1080\/21655979.2022.2047394","article-title":"Chronic intermittent hypoxia induces the pyroptosis of renal tubular epithelial cells by activating the NLRP3 inflammasome","volume":"13","author":"Bai","year":"2022","journal-title":"Bioengineered"},{"key":"2024102103085685000_61.3.2201401.42","doi-asserted-by":"crossref","first-page":"628168","DOI":"10.3389\/fimmu.2021.628168","article-title":"NLRP3 deficiency protects against intermittent hypoxia-induced neuroinflammation and mitochondrial ROS by promoting the PINK1-parkin pathway of mitophagy in a murine model of sleep apnea","volume":"12","author":"Wu","year":"2021","journal-title":"Front Immunol"},{"key":"2024102103085685000_61.3.2201401.43","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.3390\/ijerph18031319","article-title":"Endothelin-1 and LOX-1 as markers of endothelial dysfunction in obstructive sleep apnea patients","volume":"18","author":"Kosacka","year":"2021","journal-title":"Int J Environ Res Public Health"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.01401-2022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T01:12:10Z","timestamp":1740359530000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.01401-2022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,14]]},"references-count":43,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3,2]]},"published-print":{"date-parts":[[2023,3]]}},"alternative-id":["10.1183\/13993003.01401-2022"],"URL":"https:\/\/doi.org\/10.1183\/13993003.01401-2022","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,14]]}}}